ÂÜÀòÂÒÂ×

Ed Fletcher serves as the Key Account Manager at Geron Corporation since April 2024, previously holding the same position at CTI BioPharma where a new therapy for Myelofibrosis was successfully launched. Prior experience includes roles as Area Business Manager at Sanofi Genzyme, managing the launch of a Multiple Myeloma therapy during the COVID-19 pandemic, and as Senior Oncology Sales Specialist at Teva Pharmaceuticals, achieving notable recognition as a 2018 President's Club winner. Ed Fletcher also held leadership positions at CombiMatrix Laboratories and RedPath Integrated Pathology, contributing to significant sales growth and company success. Earlier roles at VantagePoint Laboratory Partners and Genoptix Medical Laboratory encompassed regional management in hematology oncology sales, demonstrating a robust background in the life sciences sector. Ed Fletcher holds a Bachelor of Science in Operations Management from Penn State University and a Master’s in Business from The Johns Hopkins University.